carmoterol
Carmoterol was being developed by the licensee company Chiesi in clinical trials as a once-daily therapy for chronic obstructive pulmonary disease. It is a non-catechol. Reference standards of Carmoterol API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Carmoterol-d3 Hydrochloride
[catalogue_number] => PA STI 018060
[category_ids] => ,80,69,71,78,70,82,98,
[chemical_name] =>
[weight] => 407.91
[form] => C21H22D3ClN2O4
[cas] => 1276319-69-7
[pslug] => 1276319-69-7-carmoterol-d3-hydrochloride-pasti018060
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Carmoterol-d3 Hydrochloride
Catalogue No.:PA STI 018060
Molecular Formula : C21H22D3ClN2O4
Molecular Weight : 407.91